세계의 헬스케어 BPO 시장, 규모, 점유율, 동향 : 아웃소싱 모델, 생명과학, 프로바이더, 보험자, 지역별 - 예측(-2030년)

The healthcare BPO market is projected to reach USD 694.3 billion by 2030, up from USD 417.7 billion in 2025, at a CAGR of 10.7% from 2025 to 2030. The growth of the healthcare BPO market is driven by increasing pressure to control rising healthcare costs and the growing reliance on outsourcing in the pharmaceutical and biopharmaceutical sectors. The integration of advanced data analytics and the rising adoption of AI-driven tools, particularly in drug discovery, are creating significant opportunities for market expansion during the forecast period. However, challenges persist, especially regarding limitations in data capture and management processes within Medicaid services, which may impede the full potential of outsourcing in certain segments of the market.

"The claims management services segment accounted for the largest share in Healthcare BPO market.''

Based on payer services, the healthcare BPO market is segmented into claims management services, integrated front-end services, back-office operations, member management services, product development and business acquisition services (PDBA), provider management services, care management services, billing and accounts management services, and HR services. In 2024, the claims management services segment accounted for the largest share of the healthcare BPO market, driven by the growing tendency of healthcare payers to outsource these critical functions. By outsourcing claims management, payer organizations can mitigate the risks of processing delays, financial penalties, and stakeholder dissatisfaction resulting from backlogs. As effective claims handling is vital for maintaining operational continuity and ensuring timely reimbursements, leveraging specialized BPO providers enables payers to enhance operational efficiency, reduce administrative costs, and improve accuracy and compliance in claims processing.

"The sales and marketing service segment accounts for the largest share of the healthcare BPO market in the non-clinical category services."

Based on the life sciences services segment, the healthcare BPO market is divided into manufacturing, research & development, and non-clinical services. The non-clinical services segment is further categorized into sales and marketing services, supply chain management and logistics services, and other non-clinical services. In 2024, the sales and marketing services segment represents the largest share in the healthcare BPO market. The dominance of sales and marketing services within the non-clinical services segment of the healthcare BPO market is primarily due to the intricate regulatory landscape of the pharmaceutical industry. As regulations constantly evolve, pharmaceutical companies are compelled to focus their resources on core activities such as research and development and production. Consequently, this has increased the demand for specialized marketing services to effectively navigate the complex regulatory environment. Additionally, the need for extensive field forces has driven the rise of contract sales organizations in the pharmaceutical sector.

"By region, North America dominated the market in the healthcare BPO market in 2024"

The healthcare BPO market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is projected to maintain a significant market share during the forecast period. This growth is expected to be driven by factors such as increasing government support for improving healthcare infrastructure, the need to reduce healthcare costs, a rising volume of claims denials and billing errors, the high number of private healthcare payers and well-established government payers, and the presence of numerous healthcare IT companies.

The break-down of primary participants is as mentioned below:

• By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3 (35%)
• By Designation: C-level (30%), Director-level (20%), and Others (50%)
• By Region: North America (42%), Europe (25%), Asia Pacific (21%), Latin America (7%), Middle East & Africa (5%)

Key Players

The major players operating in this market include Accenture plc. (Ireland), Cognizant Technology Solutions Corporation (US), Tata Consultancy Services Limited (India), Conduent Incorporated (US), WNS (Holdings) Limited (India), NTT Data Group Corporation (Japan), Iqvia Holdings Inc (US), Mphasis (India), Genpact Limited (US), Wipro Limited (India), Infosys BPM (India), Firstsource Solutions Limited (India), International Business Machines Corporation (US), GeBBS (US), Capgemini SE (France), Omega Healthcare Management Services (India), UnitedHealth Group (US), HCL Technologies Limited (India), Parexel International (MA) Corporation (US), Sutherland Global (US), 1840 & Company (US), Invensis Technologies (India), Access Healthcare (India), Vee Healthtek, Inc (US), and AGS Health (US). These companies adopted strategies such as expansions, partnerships, collaborations, and acquisitions to strengthen their market presence in the healthcare BPO market.

Research Coverage

This report examines the healthcare BPO market based on life science services, payer services, provider services, and region. It also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Additionally, it studies micro markets concerning their growth trends, prospects, and contributions to the overall healthcare BPO market. The report forecasts the revenue of the market segments in relation to five major regions.

Reasons to Buy the Report

This report will benefit established firms as well as new and smaller entrants in gauging the pulse of the market, which, in turn, will help them capture a larger share of the market. Firms purchasing the report could utilize one or a combination of the strategies mentioned below to strengthen their positions in the market.

This report also includes.

• Analysis of key drivers (shift to ICD-10 coding standards and upcoming ICD-11 standards, pressure to reduce the rising healthcare costs, loss of revenue due to billing errors, demand for niche services, need for structured processes and documentation, lack of in-house expertise in end-use industries, growing outsourcing in the pharma and biopharma industries), restraints (hidden outsourcing costs, concerns related to losing visibility and control over the business process), challenges (limitations in data capturing process in Medicaid services, data security concerns), opportunities (advanced data analytics, growing adoption of artificial intelligence-based tools for drug discovery) affecting the growth of the healthcare BPO market
• Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and service launches in the healthcare BPO market
• Market Development: Comprehensive information on the lucrative emerging markets, life science services, payer services, provider services, and regions
• Market Diversification: Exhaustive information about the growing geographies, recent developments, and investments in the healthcare BPO market
• Competitive Assessment: In-depth assessment of market share, growth strategies, service offerings, company evaluation quadrant, and capabilities of leading players in the global healthcare BPO market

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 LIFE SCIENCE SERVICE DEFINITION
  • 1.2.2 PAYER SERVICE DEFINITION
  • 1.2.3 PROVIDER SERVICE DEFINITION
  • 1.2.4 INCLUSIONS & EXCLUSIONS
• 1.3 MARKET SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 YEARS CONSIDERED
  • 1.3.3 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH APPROACH
  • 2.1.1 SECONDARY RESEARCH
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Key industry insights
• 2.2 MARKET SIZE ESTIMATION
• 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.4 STUDY ASSUMPTIONS
• 2.5 RESEARCH LIMITATIONS
  • 2.5.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.5.2 SCOPE-RELATED LIMITATIONS
• 2.6 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN HEALTHCARE BPO MARKET
• 4.2 ASIA PACIFIC: HEALTHCARE BPO MARKET, BY LIFE SCIENCE SERVICE AND COUNTRY
• 4.3 HEALTHCARE BPO MARKET: REGIONAL GROWTH OPPORTUNITIES
• 4.4 REGIONAL MIX: HEALTHCARE BPO MARKET
• 4.5 HEALTHCARE BPO NOTEBOOK MARKET: EMERGING VS. DEVELOPED ECONOMIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Shift to ICD-10 coding standards and upcoming ICD-11 standard
    • 5.2.1.2 Pressure to reduce rising healthcare costs
    • 5.2.1.3 Loss of revenue due to billing errors
    • 5.2.1.4 Demand for niche services
    • 5.2.1.5 Need for structured processes and documentation
    • 5.2.1.6 Lack of in-house expertise in end-use segments
    • 5.2.1.7 Growing outsourcing in pharma and biopharma industries
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Hidden outsourcing costs
    • 5.2.2.2 Concerns related to losing visibility and control over business process
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Advanced data analytics
    • 5.2.3.2 Growing adoption of artificial intelligence-based tools for drug discovery
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Limitations in data capturing process in Medicaid services
    • 5.2.4.2 Data security concerns
• 5.3 OUTSOURCING APPROACHES
  • 5.3.1 BUNDLED SERVICES
  • 5.3.2 FEE FOR SERVICE
  • 5.3.3 FLEXIBLE CONTRACTS
  • 5.3.4 BEST-SHORE
• 5.4 OUTSOURCING MODELS
  • 5.4.1 MULTI-SOURCING
  • 5.4.2 CAPTIVE CENTER
  • 5.4.3 HYBRID DELIVERY MODEL
  • 5.4.4 PREFERRED PROVIDER
  • 5.4.5 STRATEGIC PARTNERSHIP
  • 5.4.6 GLOBAL DELIVERY MODEL
• 5.5 INDUSTRY TRENDS
  • 5.5.1 DIGITAL TRANSFORMATION
  • 5.5.2 RISE IN TELEHEALTH AND REMOTE SERVICES
  • 5.5.3 FOCUS ON REVENUE CYCLE MANAGEMENT (RCM)
• 5.6 TECHNOLOGY ANALYSIS
  • 5.6.1 KEY TECHNOLOGIES
    • 5.6.1.1 Artificial intelligence and machine learning
    • 5.6.1.2 Robotic process automation
    • 5.6.1.3 Cloud computing
  • 5.6.2 COMPLEMENTARY TECHNOLOGIES
    • 5.6.2.1 Wearable devices and remote monitoring tools
    • 5.6.2.2 Augmented reality and virtual reality
    • 5.6.2.3 Data analytics and business intelligence
  • 5.6.3 ADJACENT TECHNOLOGIES
    • 5.6.3.1 Natural language processing (NLP)
    • 5.6.3.2 Internet of medical things
    • 5.6.3.3 Blockchain
• 5.7 SUPPLY CHAIN ANALYSIS
• 5.8 PORTER'S FIVE FORCE ANALYSIS
  • 5.8.1 THREAT OF NEW ENTRANTS
  • 5.8.2 THREAT OF SUBSTITUTES
  • 5.8.3 BARGAINING POWER OF SUPPLIERS
  • 5.8.4 BARGAINING POWER OF BUYERS
  • 5.8.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.9 REGULATORY LANDSCAPE
  • 5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.9.2 REGULATORY ANALYSIS
    • 5.9.2.1 North America
    • 5.9.2.2 Europe
    • 5.9.2.3 Asia Pacific
    • 5.9.2.4 Middle East & Africa
    • 5.9.2.5 Latin America
• 5.10 PATENT ANALYSIS
  • 5.10.1 PATENT PUBLICATION TRENDS
  • 5.10.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
• 5.11 PRICING ANALYSIS
  • 5.11.1 INDICATIVE PRICE FOR HEALTHCARE BPO, BY SERVICE TYPE (2024)
  • 5.11.2 INDICATIVE PRICE FOR HEALTHCARE BPO, BY REGION (QUALITATIVE)
• 5.12 KEY CONFERENCES AND EVENTS
• 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.13.2 BUYING CRITERIA
• 5.14 END-USER ANALYSIS
  • 5.14.1 UNMET NEEDS
  • 5.14.2 END-USER EXPECTATIONS
• 5.15 ECOSYSTEM ANALYSIS
• 5.16 CASE STUDY ANALYSIS
  • 5.16.1 CASE STUDY 1
  • 5.16.2 CASE STUDY 2
  • 5.16.3 CASE STUDY 3
• 5.17 INVESTMENT & FUNDING SCENARIO
• 5.18 IMPACT OF 2025 US TARIFF - OVERVIEW
  • 5.18.1 INTRODUCTION
  • 5.18.2 KEY TARIFF RATES
  • 5.18.3 PRICE IMPACT ANALYSIS
  • 5.18.4 IMPACT ON COUNTRY/REGION
    • 5.18.4.1 The US
    • 5.18.4.2 Europe
    • 5.18.4.3 Asia Pacific
  • 5.18.5 IMPACT ON END-USE INDUSTRIES

6 HEALTHCARE BPO MARKET, BY LIFE SCIENCE SERVICE

• 6.1 INTRODUCTION
• 6.2 MANUFACTURING
  • 6.2.1 INCREASING NEED TO REDUCE OVERALL OPERATIONAL COSTS TO DRIVE MARKET
• 6.3 RESEARCH & DEVELOPMENT
  • 6.3.1 INCREASING DEMAND FOR SPECIALIZED R&D SERVICE PROVIDERS TO DRIVE MARKET GROWTH
• 6.4 NON-CLINICAL SERVICES
  • 6.4.1 INCREASING NEED FOR ADMINISTRATIVE EFFICIENCY TO DRIVE MARKET
  • 6.4.2 SALES & MARKETING SERVICES
    • 6.4.2.1 Rising demand for strategic marketing and customer engagement to drive market
    • 6.4.2.2 Analytics
      • 6.4.2.2.1 Improved customer-facing functions and minimized risks to drive market
    • 6.4.2.3 Marketing
      • 6.4.2.3.1 Increasing focus on core functionalities to drive market
    • 6.4.2.4 Research
      • 6.4.2.4.1 Increasing focus on outsourcing research activities to drive market
    • 6.4.2.5 Forecasting
      • 6.4.2.5.1 Rapid technological advancements and shifts in consumer to drive market
    • 6.4.2.6 Performance reporting
      • 6.4.2.6.1 Availability of specialized vendors to drive market
  • 6.4.3 SUPPLY CHAIN MANAGEMENT & LOGISTICS
    • 6.4.3.1 COST-EFFECTIVE AND INNOVATIVE SUPPLY CHAIN SOLUTIONS TO DRIVE MARKET
  • 6.4.4 OTHER NON-CLINICAL SERVICES

7 HEALTHCARE BPO MARKET, BY PAYER SERVICE

• 7.1 INTRODUCTION
• 7.2 CLAIMS MANAGEMENT SERVICES
  • 7.2.1 INCREASING NEED FOR EFFICIENT, ACCURATE, AND COST-EFFECTIVE CLAIMS MANAGEMENT TO DRIVE MARKET
  • 7.2.2 CLAIMS ADJUDICATION SERVICES
    • 7.2.2.1 Scalability and flexibility to drive market
  • 7.2.3 CLAIMS SETTLEMENT SERVICES
    • 7.2.3.1 Streamlined settlement processes to drive market
  • 7.2.4 INFORMATION MANAGEMENT SERVICES
    • 7.2.4.1 Increasing need for specialized expertise to drive market
  • 7.2.5 CLAIMS REPRICING
    • 7.2.5.1 Reduced costs and enhanced service quality to drive market
  • 7.2.6 CLAIMS INVESTIGATION SERVICES
    • 7.2.6.1 Enhanced fraud detection and recovery to drive market
  • 7.2.7 CLAIMS INDEXING SERVICES
    • 7.2.7.1 Risk mitigation and compliance to drive market
  • 7.2.8 FRAUD DETECTION & MANAGEMENT SERVICES
    • 7.2.8.1 Increasing demand for social network analytics to drive market
• 7.3 INTEGRATED FRONT-END SERVICE & BACK-OFFICE OPERATIONS
  • 7.3.1 REDUCTION IN OVERHEAD EXPENSES AND IMPROVED EFFICIENCY TO DRIVE MARKET
• 7.4 MEMBER MANAGEMENT
  • 7.4.1 COST-EFFECTIVENESS AND OPERATIONAL EFFICIENCY TO DRIVE MARKET
• 7.5 PRODUCT DEVELOPMENT & BUSINESS ACQUISITION (PDBA)
  • 7.5.1 INCREASING FOCUS ON CUSTOMER ENGAGEMENT AND RETENTION TO DRIVE MARKET
• 7.6 PROVIDER MANAGEMENT
  • 7.6.1 IMPROVEMENT IN CLAIMS AUTO-ADJUDICATION RATES TO DRIVE MARKET
• 7.7 CARE MANAGEMENT
  • 7.7.1 GROWING EMPHASIS ON PATIENT SATISFACTION AND OUTCOMES TO DRIVE MARKET
• 7.8 BILLING & ACCOUNTS MANAGEMENT SERVICES
  • 7.8.1 ENHANCED BILLING ACCURACY AND EFFICIENCY TO DRIVE MARKET
• 7.9 HR SERVICES
  • 7.9.1 INCREASING NEED FOR TALENT MANAGEMENT AND WORKFORCE ANALYTICS TO DRIVE MARKET

8 HEALTHCARE BPO MARKET, BY PROVIDER SERVICE

• 8.1 INTRODUCTION
• 8.2 REVENUE CYCLE MANAGEMENT
  • 8.2.1 INCREASING OUTSOURCING OF MEDICAL BILLING AND MEDICAL CODING TO DRIVE MARKET
• 8.3 PATIENT ENROLMENT
  • 8.3.1 INCREASED CLAIM DENIALS AND PAYMENT DELAYS TO DRIVE MARKET
• 8.4 PATIENT CARE
  • 8.4.1 INCREASING NEED FOR EFFICIENT MANAGEMENT OF PATIENT INTERACTIONS AND CARE COORDINATION TO DRIVE MARKET
  • 8.4.2 MEDICAL TRANSCRIPTION
    • 8.4.2.1 Enhanced efficiency and productivity to drive market
  • 8.4.3 DEVICE MONITORING
    • 8.4.3.1 Increasing adoption of predictive analytics to drive market
  • 8.4.4 MEDICAL IMAGING
    • 8.4.4.1 Increasing need for advanced medical treatments to drive market
• 8.5 OTHER PROVIDER SERVICES

9 HEALTHCARE BPO MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 NORTH AMERICA
  • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 9.2.2 US
    • 9.2.2.1 Increasing healthcare expenditure support market growth in US
  • 9.2.3 CANADA
    • 9.2.3.1 Need for healthcare cost containment and financial management of healthcare organizations to support market growth
  • 9.2.4 EUROPE
    • 9.2.4.1 Need to reduce incidence of healthcare fraud to drive market growth
  • 9.2.5 MACROECONOMIC OUTLOOK FOR EUROPE
  • 9.2.6 GERMANY
    • 9.2.6.1 Increasing patient volume to boost adoption of RCM services
  • 9.2.7 FRANCE
    • 9.2.7.1 Government investments to increase demand for effective healthcare BPO services
  • 9.2.8 UK
    • 9.2.8.1 Integration of advanced technology to boost demand for healthcare provider BPO services
  • 9.2.9 ITALY
    • 9.2.9.1 Government-supported digital transformation to drive market
  • 9.2.10 SPAIN
    • 9.2.10.1 IT infrastructural improvements to boost market
  • 9.2.11 REST OF EUROPE
• 9.3 ASIA PACIFIC
  • 9.3.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 9.3.2 JAPAN
    • 9.3.2.1 Government mandates to boost adoption of RCM solutions
  • 9.3.3 CHINA
    • 9.3.3.1 Digitalization and improving infrastructure to support market growth
  • 9.3.4 INDIA
    • 9.3.4.1 Growing patient pool to support market growth
  • 9.3.5 REST OF ASIA PACIFIC
• 9.4 LATIN AMERICA
  • 9.4.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 9.4.2 BRAZIL
    • 9.4.2.1 Brazil to dominate Latin American healthcare BPO market
  • 9.4.3 MEXICO
    • 9.4.3.1 Rising healthcare costs to boost market growth
  • 9.4.4 REST OF LATIN AMERICA
• 9.5 MIDDLE EAST & AFRICA
  • 9.5.1 INCREASING INVESTMENTS IN MODERNIZING HEALTHCARE SYSTEMS TO BOOST MARKET GROWTH
  • 9.5.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 9.5.3 GCC COUNTRIES
    • 9.5.3.1 Healthcare sector expansion and strategic investments to drive market
  • 9.5.4 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE BPO MARKET
• 10.3 REVENUE ANALYSIS, 2020-2024
• 10.4 MARKET SHARE ANALYSIS
• 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 10.5.1 STARS
  • 10.5.2 EMERGING LEADERS
  • 10.5.3 PERVASIVE PLAYERS
  • 10.5.4 PARTICIPANTS
  • 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 10.5.5.1 Region footprint
    • 10.5.5.2 Provider service footprint
    • 10.5.5.3 Payer service footprint
    • 10.5.5.4 Life science service footprint
• 10.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2024
  • 10.6.1 PROGRESSIVE COMPANIES
  • 10.6.2 DYNAMIC COMPANIES
  • 10.6.3 RESPONSIVE COMPANIES
  • 10.6.4 STARTING BLOCKS
  • 10.6.5 COMPETITIVE BENCHMARKING
    • 10.6.5.1 Detailed list of key start-ups/SMEs
    • 10.6.5.2 Competitive benchmarking of key start-ups/SMEs
• 10.7 COMPANY VALUATION & FINANCIAL METRICS
• 10.8 BRAND/PRODUCT COMPARISON ANALYSIS
• 10.9 COMPETITIVE SCENARIO
  • 10.9.1 DEALS
  • 10.9.2 EXPANSIONS
  • 10.9.3 OTHER DEVELOPMENTS

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
  • 11.1.1 ACCENTURE PLC
    • 11.1.1.1 Business overview
    • 11.1.1.2 Services offered
    • 11.1.1.3 Recent developments
      • 11.1.1.3.1 Deals
    • 11.1.1.4 MnM view
      • 11.1.1.4.1 Right to win
      • 11.1.1.4.2 Strategic choices
      • 11.1.1.4.3 Weaknesses & competitive threats
  • 11.1.2 COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION
    • 11.1.2.1 Business overview
    • 11.1.2.2 Services offered
    • 11.1.2.3 Recent developments
      • 11.1.2.3.1 Deals
    • 11.1.2.4 MnM view
      • 11.1.2.4.1 Right to win
      • 11.1.2.4.2 Strategic choices
      • 11.1.2.4.3 Weaknesses & competitive threats
  • 11.1.3 TATA CONSULTING SERVICES LIMITED
    • 11.1.3.1 Business overview
    • 11.1.3.2 Services offered
    • 11.1.3.3 Recent developments
      • 11.1.3.3.1 Deals
      • 11.1.3.3.2 Other developments
    • 11.1.3.4 MnM view
      • 11.1.3.4.1 Right to win
      • 11.1.3.4.2 Strategic choices
      • 11.1.3.4.3 Weaknesses & competitive threats
  • 11.1.4 WNS (HOLDINGS) LIMITED
    • 11.1.4.1 Business overview
    • 11.1.4.2 Services offered
    • 11.1.4.3 Recent developments
      • 11.1.4.3.1 Deals
      • 11.1.4.3.2 Expansions
      • 11.1.4.3.3 Other developments
    • 11.1.4.4 MnM view
      • 11.1.4.4.1 Right to win
      • 11.1.4.4.2 Strategic choices
      • 11.1.4.4.3 Weaknesses & competitive threats
  • 11.1.5 NTT DATA
    • 11.1.5.1 Business overview
    • 11.1.5.2 Services offered
    • 11.1.5.3 Recent developments
      • 11.1.5.3.1 Deals
      • 11.1.5.3.2 Expansions
    • 11.1.5.4 MnM view
      • 11.1.5.4.1 Right to win
      • 11.1.5.4.2 Strategic choices
      • 11.1.5.4.3 Weaknesses & competitive threats
  • 11.1.6 CONDUENT INCORPORATED
    • 11.1.6.1 Business overview
    • 11.1.6.2 Services offered
    • 11.1.6.3 Recent developments
      • 11.1.6.3.1 Deals
  • 11.1.7 IQVIA HOLDINGS INC.
    • 11.1.7.1 Business overview
    • 11.1.7.2 Services offered
    • 11.1.7.3 Recent developments
      • 11.1.7.3.1 Deals
      • 11.1.7.3.2 Other developments
  • 11.1.8 MPHASIS
    • 11.1.8.1 Business overview
    • 11.1.8.2 Services offered
    • 11.1.8.3 Recent developments
      • 11.1.8.3.1 Deals
      • 11.1.8.3.2 Expansions
      • 11.1.8.3.3 Other developments
  • 11.1.9 GENPACT LIMITED
    • 11.1.9.1 Business overview
    • 11.1.9.2 Services offered
    • 11.1.9.3 Recent developments
      • 11.1.9.3.1 Deals
      • 11.1.9.3.2 Expansions
  • 11.1.10 WIPRO LIMITED
    • 11.1.10.1 Business overview
    • 11.1.10.2 Services offered
    • 11.1.10.3 Recent developments
      • 11.1.10.3.1 Deals
      • 11.1.10.3.2 Other developments
  • 11.1.11 INFOSYS BPM
    • 11.1.11.1 Business overview
    • 11.1.11.2 Services offered
  • 11.1.12 FIRSTSOURCE SOLUTIONS LIMITED
    • 11.1.12.1 Business overview
    • 11.1.12.2 Services offered
    • 11.1.12.3 Recent developments
      • 11.1.12.3.1 Deals
      • 11.1.12.3.2 Expansions
  • 11.1.13 INTERNATIONAL BUSINESS MACHINES CORPORATION
    • 11.1.13.1 Business overview
    • 11.1.13.2 Services offered
    • 11.1.13.3 Recent developments
      • 11.1.13.3.1 Other developments
  • 11.1.14 GEBBS
    • 11.1.14.1 Business overview
    • 11.1.14.2 Services offered
    • 11.1.14.3 Recent developments
      • 11.1.14.3.1 Deals
  • 11.1.15 CAPGEMINI SE
    • 11.1.15.1 Business overview
    • 11.1.15.2 Services offered
  • 11.1.16 UNITEDHEALTH GROUP INCORPORATED
    • 11.1.16.1 Business overview
    • 11.1.16.2 Services offered
  • 11.1.17 HCL TECHNOLOGIES LIMITED
    • 11.1.17.1 Business overview
    • 11.1.17.2 Services offered
    • 11.1.17.3 Recent developments
      • 11.1.17.3.1 Deals
  • 11.1.18 PAREXEL INTERNATIONAL (MA) CORPORATION
    • 11.1.18.1 Business overview
    • 11.1.18.2 Services offered
    • 11.1.18.3 Recent developments
      • 11.1.18.3.1 Deals
  • 11.1.19 SUTHERLAND
    • 11.1.19.1 Business overview
    • 11.1.19.2 Services offered
  • 11.1.20 OMEGA HEALTHCARE MANAGEMENT SERVICES
    • 11.1.20.1 Business overview
    • 11.1.20.2 Services offered
      • 11.1.20.2.1 Other developments
• 11.2 OTHER PLAYERS
  • 11.2.1 1840 & COMPANY
  • 11.2.2 INVENSIS TECHNOLOGIES PVT LTD
  • 11.2.3 ACCESS HEALTHCARE
  • 11.2.4 VEE HEALTHTEK, INC.
  • 11.2.5 AGS HEALTH

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS